Delivery Order SPE2DB20D9127-SPE2DB23FPQW7
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $37,053.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Trikafta, a specialized pharmaceutical product, with an ultimate completion date of April 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $53,193.27 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Trikafta, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- The U.S. Defense Logistics Agency (DLA) awarded a $18,526.83 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order for the drug Trikafta is being fulfilled under a larger single-award indefinite delivery contract (IDC), valued up to $499,999,999, awarded to DMS by the DLA. The IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has no set-aside designation, is for the delivery of the prescription drug Trikafta, and has an ultimate completion date of July 12, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the delivery of TRIKAFTA 100-50-75 MG/75MG PKT 14S, a specialized pharmaceutical product, with a period of performance through October 12, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, with a period of performance through April 1, 2024, is for the delivery of the pharmaceutical product Trikafta 100-50-75 mg/150 mg. This award is issued under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract SPE2DB22D9102 with DLA, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the drug Trikafta, with a completion date of February 13, 2024. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding a separate indefinite delivery contract with DLA valued at up to $4,999,999 through 2025 to provide a wide range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $36,637.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the delivery of Trikafta tablets, which are used to treat cystic fibrosis. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $36,976.24 by the Defense Logistics Agency (DLA) on July 31, 2025, with an ultimate completion date of August 1, 2025. The delivery order, issued under a firm fixed-price contract structure with no set-aside designation, covers the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). Performance will occur at the contractor's...
- The U.S. Defense Logistics Agency (DLA) awarded a $18,474.02 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which is not associated with a set-aside designation, is for the delivery of the drug Trikafta 50-25-37.5 mg/75 mg. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract with the DLA under the SPE2DB program, which allows the agency to issue...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB23FPQW7Delivery Order
The Defense Logistics Agency (DLA) awarded a $51,136.76 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Trikafta 100-50-75 mg/75 mg packets, a specialized pharmaceutical product, with a performance period through June 26, 2023. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which covers a comprehensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure this direct federal award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $51.1k | 6/23/23 |